Literature DB >> 26172859

Preventing birth defects: The value of the NBDPS case-control approach.

Helen Dolk1.   

Abstract

Birth Defect Registries provide a basis for epidemiological research into risk factors, thus facilitating a growing understanding of what causes congenital anomalies and how one might target preventive public health actions and reduce inequalities. The National Birth Defects Prevention Study (NBDPS) has used 10 U.S. registries as a basis for a large case-control study. This commentary reviews its methodology and selected areas of output. The strengths of NBDPS lie in the quality of diagnostic coding and classification of birth defects and its size. The sources of bias in NBDPS data relate particularly to retrospective exposure ascertainment entailing a long period of recall, incomplete ascertainment of terminations of pregnancy for fetal anomaly, and unknown bias in case selection. NBDPS results have shown the protective effect of healthy dietary patterns, but have not been as informative as expected in relation to furthering understanding of the protective effect of folic acid. NBDPS medication studies are making important contributions to addressing the gap in existing evidence systematically across a wide range of birth defects, but are challenged by the quality of information on exposure, dose and underlying disease condition, and the interpretation of results of multiple testing. Studies of environmental contaminants in collaboration with experts in exposure assessment have linked addresses to residential exposure measures, using the advantages of information on residential history and confounders, but are challenged by the need to consider exposure mixtures. NBDPS could increase its public health impact by placing more emphasis on socioeconomic inequalities.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  birth defects; case-control; risk factors

Mesh:

Year:  2015        PMID: 26172859     DOI: 10.1002/bdra.23404

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  5 in total

1.  Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.

Authors:  Cynthia A Moore; Paula W Yoon; Larry D Edmonds; J David Erickson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

2.  Population-based birth defects data in the United States, 2008 to 2012: Presentation of state-specific data and descriptive brief on variability of prevalence.

Authors:  Cara T Mai; Jennifer Isenburg; Peter H Langlois; C J Alverson; Suzanne M Gilboa; Russel Rickard; Mark A Canfield; Suzanne B Anjohrin; Philip J Lupo; Deanna R Jackson; Erin B Stallings; Angela E Scheuerle; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-11

3.  Descriptive and risk factor analysis of nonsyndromic sacral agenesis: National Birth Defects Prevention Study, 1997-2011.

Authors:  Marine Nalbandyan; Meredith M Howley; Christopher M Cunniff; Paul A Romitti; Marilyn L Browne
Journal:  Am J Med Genet A       Date:  2019-07-11       Impact factor: 2.802

4.  The Baby Hearts Study - a case-control methodology with data linkage to evaluate risk and protective factors for congenital heart disease.

Authors:  N McCullough; H Dolk; M Loane; B M Lagan; F Casey; B Craig
Journal:  Int J Popul Data Sci       Date:  2019-04-08

5.  Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.

Authors:  Jun Zhu; Xiaohong Li; Yangwen Zhou; Jing Tao; Ke Wang; Kui Deng; Yanping Wang; Jianxin Zhao; Chunyi Chen; Tingxuan Wu; Jiayuan Zhou
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-01       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.